News

news-preview-placeholder
Congrats to Jennie Rivers on 25 Years with Carlisle & Associates!

It is with great pride that we announce Jennie Rivers’ 25th anniversary at Carlisle &…

Mar 18, 2013
news-preview-placeholder
Changes to the Controlled Substance Schedules – New York

Changes to the Controlled Substance Schedules in Section 3306 of the New York State Public…

Mar 12, 2013
news-preview-placeholder
Generic Zometa® Launches

Generic Zometa® Launches – On March 5, 2013, Sagent Pharmaceuticals received final FDA approval and…

Mar 11, 2013
news-preview-placeholder
Generic Suboxone® Launches

On March 5, 2013, Amneal Pharmaceuticals LLC announced that its generic equivalent of Suboxone®, Buprenorphine…

news-preview-placeholder
Generic Antara® Launches

On Friday, February 22, Mylan received final FDA approval and launched the generic equivalent of…

Mar 04, 2013
news-preview-placeholder
Generic Sulfamylon® Launches

On February 2, 2013, Par Pharmaceutical received final FDA approval for and commenced shipping the…

Feb 18, 2013
news-preview-placeholder
Illinois – Final Physician-Dispensed Pharmacy Rule Published

The IWCC’s final repackaged drug repricing methodology was published in the December 7 edition of…

Feb 06, 2013
news-preview-placeholder
Generic Olux E Foam® Launches

On February 1, 2013, Perrigo received final FDA approval for and commenced shipping the generic…

Feb 04, 2013
news-preview-placeholder
Generic Bactroban® Launches

On January 25, 2013, Glenmark received final FDA approval for and commenced shipping the generic…

Jan 28, 2013
news-preview-placeholder
Generic Clarinex Reditabs® Launch

On January 23, 2013, Dr. Reddy’s Laboratories commenced shipping the generic equivalent for Merck’s branded…

  • This field is for validation purposes and should be left unchanged.


Filter Articles

Should a claimant need this much pain medication for this long? Are claimants utilizing medications or selling on the black market?

The prevalence of opioid use and abuse among those with chronic pain has developed into one of the most pressing issues today. Download the white paper to learn facts about the opioid crisis and possible solutions to avoid prescriptions that could lead to abuse.

Download Now